A federal appeals court ruled Monday that Alabama can enforce a ban outlawing the use of puberty blockers and hormones to treat transgender children, the second such appellate victory for gender-affirming care restrictions that have been adopted by a growing number of Republican-led states.
A three-judge panel of the 11th U.S. Circuit Court of Appeals vacated a judge’s temporary injunction against enforcing the law. The judge has scheduled trial for April 2 on whether to permanently block the law.
Alabama Attorney General Steve Marshall called the ruling a "significant victory for our country, for children, and for common sense.”
“The Eleventh Circuit reinforced that the State has the authority to safeguard the physical and psychological wellbeing of minors,” Marshall said.
In lifting the injunction, the judges wrote that states have “a compelling interest in protecting children from drugs, particularly those for which there is uncertainty regarding benefits, recent surges in use, and irreversible effects.”
The decision leaves families of transgender children, who had been receiving treatment, scrambling for care. The injunction will remain in place until the court issues the mandate, which could take several days. But once it is officially lifted, the attorney general's office will be able to enforce the ban, which threatens doctors with prison time.
Advocacy groups representing families who challenged the Alabama law vowed to continue the fight, saying “parents, not the government, are best situated to make these medical decisions for their children.”
“Our clients are devastated by this decision, which leaves them vulnerable to what the district court—after hearing several days of testimony from parents, doctors, and experts—found to be irreparable harm as a result of losing the medical care they have been receiving and that has enabled them to thrive,” said a joint statement from the Southern Poverty Law Center, the National Center for Lesbian Rights, GLBTQ Legal Advocates & Defenders, and the Human Rights Campaign.
Major medical groups, including the American Medical Association and the American Academy of Pediatrics, oppose the bans and experts say treatments are safe if properly administered.
Puberty blockers are fully reversible prescription medication that pause sexual maturation, typically given in injections or skin implants. Hormone treatments can prompt sexual development, including changes in appearance.
Dr. Morissa Ladinsky, a Birmingham pediatrician, said in a statement Monday that she is hopeful “today’s decision is just a temporary setback.”
“As a doctor who has treated hundreds of transgender adolescents, I know firsthand the challenges these young people and their families face and the benefits these treatments provide to youth who need them. This is safe, effective, and established medical care. There is no valid reason to ban this care,” Ladinsky said.
The ruling follows a string of decisions in recent weeks against similar bans. A federal judge in June struck down a similar law in Arkansas, the first state to enact such a ban. At least 20 states enacted laws restricting or banning gender-affirming care for minors.
Opponents of youth transgender medical treatment say there’s no solid proof of purported benefits, cite widely discredited research and say children shouldn’t make life-altering decisions they might regret.
Bans have also been temporarily blocked by federal judges in Florida, Indiana, and Kentucky. A federal appeals court has allowed Tennessee’s ban, which had been blocked by a federal judge, to take effect.
The ruling applies to only the Alabama ban, but comes as most of the state bans are being challenged in court.
Alabama Gov. Kay Ivey signed the Vulnerable Child Compassion and Protection Act into law in 2022, making it a felony punishable by up to 10 years in prison for doctors to treat people under 19 with puberty blockers or hormones to help affirm their gender identity.
Four families with transgender children ranging in ages 12 to 17 challenged the Alabama law as an unconstitutional violation of equal protection and free speech rights, as well as an intrusion into family medical decisions. The U.S. Department of Justice joined their lawsuit, seeking to overturn the law.
U.S. District Judge Liles Burke, who was nominated to the court by President Donald Trump in 2017, ruled when issuing the preliminary injunction that Alabama had produced no credible evidence to show that transitioning medications are “experimental.”
Alabama then appealed to the 11th Circuit.
Burke allowed two other parts of the law to take effect. One bans gender-affirming surgeries for transgender minors, which doctors had testified are not done on minors in Alabama. The other requires counselors and other school officials to tell parents if a minor discloses that they think they are transgender.
More GOP states are poised to enact similar bans on gender-affirming care for minors. Democratic governors in Louisiana and North Carolina have vetoed bans, but both are expected to be overridden by Republican-led legislatures.
